Biomerics , the leading vertically integrated contract manufacturer for the interventional medical device market, announced that it has entered into definitive agreements to merge...
Amgen presented new compelling data from the Phase 3 FOURIER open label extension (OLE) studies of Repatha (evolocumab) in adults with atherosclerotic cardiovascular disease...
Tamer, the Middle-East's leading healthcare distribution company, has agreed a 5-year deal to bring Huma's market leading technology platform to power 'hospitals at home'...
